Tan Ho

Array ( [id] => 8989762 [patent_doc_number] => 20130217043 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-22 [patent_title] => 'HUMANIZED TRANSGENIC MOUSE MODEL' [patent_app_type] => utility [patent_app_number] => 13/581483 [patent_app_country] => US [patent_app_date] => 2011-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 6172 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13581483 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7742388 [patent_doc_number] => 20120021019 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'CARDIAC STEM CELL POPULATIONS FOR REPAIR OF CARDIAC TISSUE' [patent_app_type] => utility [patent_app_number] => 13/245787 [patent_app_country] => US [patent_app_date] => 2011-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 9338 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20120021019.pdf [firstpage_image] =>[orig_patent_app_number] => 13245787 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7770822 [patent_doc_number] => 20120036590 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-09 [patent_title] => 'INTERFERON-LIKE PROTEIN ZCYTO21' [patent_app_type] => utility [patent_app_number] => 13/227548 [patent_app_country] => US [patent_app_date] => 2011-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 25271 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20120036590.pdf [firstpage_image] =>[orig_patent_app_number] => 13227548 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8138653 [patent_doc_number] => 20120093879 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-19 [patent_title] => 'CARDIAC STEM CELLS AND USES OF SAME IN CARDIAC REPAIR' [patent_app_type] => utility [patent_app_number] => 13/214742 [patent_app_country] => US [patent_app_date] => 2011-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 9188 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20120093879.pdf [firstpage_image] =>[orig_patent_app_number] => 13214742 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7783865 [patent_doc_number] => 20120045421 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-23 [patent_title] => 'METHODS FOR THE ISOLATION OF CARDIAC STEM CELLS' [patent_app_type] => utility [patent_app_number] => 13/214680 [patent_app_country] => US [patent_app_date] => 2011-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9186 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20120045421.pdf [firstpage_image] =>[orig_patent_app_number] => 13214680 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9085825 [patent_doc_number] => 08557248 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-15 [patent_title] => 'Methods and compositions for treating malaria' [patent_app_type] => utility [patent_app_number] => 13/206471 [patent_app_country] => US [patent_app_date] => 2011-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 21 [patent_no_of_words] => 33679 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13206471 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8172446 [patent_doc_number] => 20120107923 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-03 [patent_title] => 'EXPRESSION VECTORS WHICH INHIBIT SYNTHESIS OF CATALASE AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/197076 [patent_app_country] => US [patent_app_date] => 2011-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2871 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20120107923.pdf [firstpage_image] =>[orig_patent_app_number] => 13197076 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7754542 [patent_doc_number] => 20120027727 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'TARGETED NANOPARTICLES FOR CANCER AND OTHER DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/184458 [patent_app_country] => US [patent_app_date] => 2011-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 51058 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20120027727.pdf [firstpage_image] =>[orig_patent_app_number] => 13184458 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8846064 [patent_doc_number] => 08455243 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-04 [patent_title] => 'LRRK2 polynucleotides' [patent_app_type] => utility [patent_app_number] => 13/172412 [patent_app_country] => US [patent_app_date] => 2011-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 5 [patent_no_of_words] => 5708 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13172412 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9181221 [patent_doc_number] => 20130323206 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-05 [patent_title] => 'GENE DELIVERY SYSTEM HAVING ENHANCED TUMOR-SPECIFIC EXPRESSION, AND RECOMBINANT GENE EXPRESSION REGULATING SEQUENCE' [patent_app_type] => utility [patent_app_number] => 13/878266 [patent_app_country] => US [patent_app_date] => 2011-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 9988 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13878266 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9006591 [patent_doc_number] => 20130227716 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-29 [patent_title] => 'METHODS AND COMPOSITIONS FOR TARGETED PROTEIN DEGRADATION' [patent_app_type] => utility [patent_app_number] => 13/702988 [patent_app_country] => US [patent_app_date] => 2011-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 14433 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13702988 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8953096 [patent_doc_number] => 20130198876 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-01 [patent_title] => 'INDUCED MALIGNANT STEM CELLS OR PRE-INDUCTION CANCER STEM CELLS CAPABLE OF SELFREPLICATION OUTSIDE OF AN ORGANISM, PRODUCTION METHOD FOR SAME, AND PRACTICAL APPLICATION FOR SAME' [patent_app_type] => utility [patent_app_number] => 13/699431 [patent_app_country] => US [patent_app_date] => 2011-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 39829 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13699431 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7586846 [patent_doc_number] => 20110281356 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'COMPOUNDS FOR STEM CELL DIFFERENTIATION' [patent_app_type] => utility [patent_app_number] => 13/107592 [patent_app_country] => US [patent_app_date] => 2011-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 21101 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20110281356.pdf [firstpage_image] =>[orig_patent_app_number] => 13107592 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9162181 [patent_doc_number] => 20130310458 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-21 [patent_title] => 'Sensors For The Detection Of Intracellular Metabolites' [patent_app_type] => utility [patent_app_number] => 13/695769 [patent_app_country] => US [patent_app_date] => 2011-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 16746 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13695769 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7670209 [patent_doc_number] => 20110319478 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'Compositions to Treat Cardiac Pacing Conditions' [patent_app_type] => utility [patent_app_number] => 13/096193 [patent_app_country] => US [patent_app_date] => 2011-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 13868 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13096193 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8280369 [patent_doc_number] => 20120174241 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-05 [patent_title] => 'Mouse model for diagnosis of T cell acute lymphoblastic leukemia and for screening of therapeutic agents, and methods of use therefor' [patent_app_type] => utility [patent_app_number] => 13/066750 [patent_app_country] => US [patent_app_date] => 2011-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 16453 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13066750 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6163512 [patent_doc_number] => 20110160292 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-30 [patent_title] => 'Regulation of Integrin Surface Expression' [patent_app_type] => utility [patent_app_number] => 13/042054 [patent_app_country] => US [patent_app_date] => 2011-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14627 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20110160292.pdf [firstpage_image] =>[orig_patent_app_number] => 13042054 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7651356 [patent_doc_number] => 20110300625 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => 'TISSUE FOR PROSTHETIC IMPLANTS AND GRAFTS, AND METHODS ASSOCIATED THEREWITH' [patent_app_type] => utility [patent_app_number] => 13/038260 [patent_app_country] => US [patent_app_date] => 2011-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6822 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0300/20110300625.pdf [firstpage_image] =>[orig_patent_app_number] => 13038260 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5958554 [patent_doc_number] => 20110182941 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-28 [patent_title] => 'Alphavirus and Alphavirus Replicon Particle Formulations and Methods' [patent_app_type] => utility [patent_app_number] => 13/012714 [patent_app_country] => US [patent_app_date] => 2011-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 17331 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20110182941.pdf [firstpage_image] =>[orig_patent_app_number] => 13012714 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7742185 [patent_doc_number] => 20120020929 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'METHODS AND COMPOSITIONS RELATING TO NEURONAL CELL AND TISSUE DIFFERENTIATION' [patent_app_type] => utility [patent_app_number] => 13/009595 [patent_app_country] => US [patent_app_date] => 2011-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 34900 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20120020929.pdf [firstpage_image] =>[orig_patent_app_number] => 13009595 [rel_patent_id] =>[rel_patent_doc_number] =>)